Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of Statins.

Clinics in laboratory medicine - 1 Sept 2016

Ruaño Gualberto, Seip Richard, Windemuth Andreas, Wu Alan H B, Thompson Paul D

Abstract excerpt

Statin responsiveness is an area of great research interest given the success of the drug class in the treatment of hypercholesterolemia and in primary and secondary prevention of cardiovascular disease. Interrogation of the patient's genome for gene variants will eventually guide anti-hyperlipidemic intervention. In this review, we discuss methodological approaches to discover genetic markers predictive of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Decision Support Systems, Clinical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Hypercholesterolemia

Share to Laboratories

Share to Pharmacogenomic Variants

Share to Primary Prevention

Share to Secondary Prevention

Source

Open in PubMed Open full text

Identifiers

PMID: 27514463
DOI: 10.1016/j.cll.2016.05.010
PMCID: PMC4987540

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of Statins.PMID 27514463Read ↗

Genetics and personalized medicine--a role in statin therapy?Semantic proximity Read ↗

Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics.Semantic proximity Read ↗

Gene-drug interactions identify genomic loci that enhance statin effectiveness in lowering LDL cholesterolSemantic proximity Read ↗

Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease.Semantic proximity Read ↗

Pharmacogenomics of blood lipid regulation.Semantic proximity Read ↗

Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial HypercholesterolemiaSemantic proximity Read ↗

A factorial Mendelian randomization study to systematically prioritize genetic targets for the treatment of cardiovascular diseaseSemantic proximity Read ↗

Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy.Semantic proximity Read ↗

Pharmacogenetics: the outlook for genetic testing in statin therapy.Semantic proximity Read ↗

Pharmacogenomics of cholesterol-lowering therapy.Semantic proximity Read ↗

Genetics of cholesterol and lipoprotein metabolism.Semantic proximity Read ↗

DNA testing for familial hypercholesterolemia: improving disease recognition and patient care.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.